NCT04950218 Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
| NCT ID | NCT04950218 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Herlev and Gentofte Hospital |
| Condition | Psoriasis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2034-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2021-09-01 with a primary completion date of 2034-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.
Eligibility Criteria
Inclusion Criteria: * Patients 18 years or older with a diagnosis of psoriasis will be invited to participate Exclusion Criteria: * Patients not able to cooperate to the study * Patients unable understand and sign informed consent
Contact & Investigator
Tor Biering-Sørensen, MD, PhD, MPH
STUDY DIRECTOR
Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen
Frequently Asked Questions
Who can join the NCT04950218 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Psoriasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04950218 currently recruiting?
Yes, NCT04950218 is actively recruiting participants. Contact the research team at mariaflarupdons@hotmail.com for enrollment information.
Where is the NCT04950218 trial being conducted?
This trial is being conducted at Hellerup, Denmark.
Who is sponsoring the NCT04950218 clinical trial?
NCT04950218 is sponsored by Herlev and Gentofte Hospital. The principal investigator is Tor Biering-Sørensen, MD, PhD, MPH at Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.